134 related articles for article (PubMed ID: 8458401)
1. Dihydropyridine Ca2+ channel antagonists inhibit the salvage pathway for DNA synthesis in human vascular smooth muscle cells.
Agrotis A; Little PJ; Saltis J; Bobik A
Eur J Pharmacol; 1993 Feb; 244(3):269-75. PubMed ID: 8458401
[TBL] [Abstract][Full Text] [Related]
2. Anti-proliferative effects of benidipine hydrochloride in porcine cultured vascular smooth muscle cells and in rats subjected to balloon catheter-induced endothelial denudation.
Ide S; Kondoh M; Satoh H; Karasawa A
Biol Pharm Bull; 1994 May; 17(5):627-31. PubMed ID: 7920421
[TBL] [Abstract][Full Text] [Related]
3. Action of dihydropyridine calcium antagonists on early growth response gene expression and cell growth in vascular smooth muscle cells.
Ko Y; Totzke G; Graack GH; Heidgen FJ; Meyer zu Brickwedde MK; Düsing R; Vetter H; Sachinidis A
J Hypertens; 1993 Nov; 11(11):1171-8. PubMed ID: 8301097
[TBL] [Abstract][Full Text] [Related]
4. Diltiazem inhibits DNA synthesis and Ca2+ uptake induced by insulin, IGF-I, and PDGF in vascular smooth muscle cells.
Fujiwara R; Hayashi T; Nakai T; Miyabo S
Cardiovasc Drugs Ther; 1994 Dec; 8(6):861-9. PubMed ID: 7742265
[TBL] [Abstract][Full Text] [Related]
5. Calcium influx modulates DNA synthesis and proliferation in A7r5 vascular smooth muscle cells.
Sperti G; Colucci WS
Eur J Pharmacol; 1991 Apr; 206(4):279-84. PubMed ID: 1915588
[TBL] [Abstract][Full Text] [Related]
6. Calcium channel blockers inhibit cellular uptake of thymidine, uridine and leucine: the incorporation of these molecules into DNA, RNA and protein in the presence of calcium channel blockers is not a valid measure of lymphocyte activation.
Weir MR; Peppler R; Gomolka D; Handwerger BS
Immunopharmacology; 1993; 25(1):75-82. PubMed ID: 7686541
[TBL] [Abstract][Full Text] [Related]
7. Effects of calcium-antagonists and calmodulin inhibitors on DNA synthesis in cultured rat vascular smooth muscle cells.
Tomita M; Hirata Y; Takata S; Fujita T
Endocrinol Jpn; 1987 Apr; 34(2):313-8. PubMed ID: 3497799
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of PDGF-mediated proliferation of vascular smooth muscle cells by calcium antagonists.
Kataoka S; Alam R; Dash PK; Yatsu FM
Stroke; 1997 Feb; 28(2):364-9. PubMed ID: 9040691
[TBL] [Abstract][Full Text] [Related]
9. Effects of nicorandil on cell proliferation and cholesteryl ester accumulation in arterial smooth muscle cells in culture.
Fujiwara R; Hayashi T; Kutsumi Y; Oida K; Tamai T; Nakai T; Miyabo S
Cardiovasc Drugs Ther; 1993 Jun; 7(3):365-72. PubMed ID: 8395877
[TBL] [Abstract][Full Text] [Related]
10. Felodipine inhibits nuclear translocation of p42/44 mitogen-activated protein kinase and human smooth muscle cell growth.
Yang Z; Madinova A; Kozai T; Joch H; Aebi U; Lüscher TF
Cardiovasc Res; 2002 Jan; 53(1):227-31. PubMed ID: 11744032
[TBL] [Abstract][Full Text] [Related]
11. Effect of calcium channel blockers on the growth of human vascular smooth muscle cells derived from saphenous vein and vascular graft stenoses.
Munro E; Patel M; Chan P; Betteridge L; Gallagher K; Schachter M; Wolfe J; Sever P
J Cardiovasc Pharmacol; 1994 May; 23(5):779-84. PubMed ID: 7521461
[TBL] [Abstract][Full Text] [Related]
12. Membrane stretch evoked by cell swelling increases contractile activity in vascular smooth muscle through dihydropyridine-sensitive pathways.
Bülow A; Johansson B
Acta Physiol Scand; 1994 Dec; 152(4):419-27. PubMed ID: 7701942
[TBL] [Abstract][Full Text] [Related]
13. Comparative study of calcium-channel blockers on cell proliferation, DNA and collagen syntheses, and EGF receptors of cultured gingival fibroblasts derived from human nifedipine, nicardipine and nisoldipine responders.
Matsumoto H; Noji I; Akimoto Y; Fujii A
J Oral Sci; 2001 Dec; 43(4):261-8. PubMed ID: 11848193
[TBL] [Abstract][Full Text] [Related]
14. Antiproliferative effects of PCA-4230, a new antithrombotic drug, in vascular smooth muscle cells.
del Rio M; Sunkel C; Larcher F; Ortega MP
Br J Pharmacol; 1997 Apr; 120(7):1360-6. PubMed ID: 9105713
[TBL] [Abstract][Full Text] [Related]
15. cGMP-elevating agents suppress proliferation of vascular smooth muscle cells by inhibiting the activation of epidermal growth factor signaling pathway.
Yu SM; Hung LM; Lin CC
Circulation; 1997 Mar; 95(5):1269-77. PubMed ID: 9054859
[TBL] [Abstract][Full Text] [Related]
16. Effect of serum withdrawal on the contribution of L-type calcium channels (CaV1.2) to intracellular Ca2+ responses and chemotaxis in cultured human vascular smooth muscle cells.
Patel MK; Clunn GF; Lymn JS; Austin O; Hughes AD
Br J Pharmacol; 2005 Jul; 145(6):811-7. PubMed ID: 15880143
[TBL] [Abstract][Full Text] [Related]
17. Calcium antagonists differently inhibit proliferation of human coronary smooth muscle cells in response to pulsatile stretch and platelet-derived growth factor.
Yang Z; Noll G; Lüscher TF
Circulation; 1993 Sep; 88(3):832-6. PubMed ID: 8353912
[TBL] [Abstract][Full Text] [Related]
18. Effect of elastase on aortic smooth muscle cell proliferation.
Kawaguchi H; Sano H; Kudo T; Yasuda H
Jpn Heart J; 1991 Jan; 32(1):131-8. PubMed ID: 2038118
[TBL] [Abstract][Full Text] [Related]
19. Effects of verapamil, diltiazem, nisoldipine and felodipine on sarcoplasmic reticulum.
Wang T; Tsai LI; Schwartz A
Eur J Pharmacol; 1984 May; 100(3-4):253-61. PubMed ID: 6234179
[TBL] [Abstract][Full Text] [Related]
20. Effects of felodipine, nifedipine and verapamil on cytosolic Ca2+ and contraction in vascular smooth muscle.
Hagiwara S; Mitsui M; Karaki H
Eur J Pharmacol; 1993 Mar; 234(1):1-7. PubMed ID: 7682512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
